NR 565 | Original Practice Examination | 2026/2027 Page 1
, NR 565 Midterm & Final Exams | Advanced Pharmacology | Chamberlain | 100 Q & A | 2026/2027
NR 565 MIDTERM EXAM
Advanced Pharmacology Fundamentals
Chamberlain University
100-Question Original Practice Examination
2026/2027 Edition
1. An oral medicine has extensive first-pass hepatic metabolism. Compared with an equal intravenous
dose, which result is most likely?
A) Elimination of hepatic exposure
B) An unchanged fraction reaching circulation
C) Higher absolute bioavailability
D) Lower systemic bioavailability
Correct Answer: Lower systemic bioavailability
Rationale: First-pass extraction removes some absorbed drug before it reaches systemic circulation. Intravenous
dosing bypasses intestinal absorption and the initial portal passage. Oral dose adjustments may therefore be
necessary, but the effect depends on the specific drug and liver function.
2. A medicine is 98% albumin-bound. Severe hypoalbuminemia is most likely to cause which immediate
change?
A) A complete loss of drug effect
B) A higher free fraction of drug
C) A fixed increase in renal clearance
D) A higher measured albumin concentration
Correct Answer: A higher free fraction of drug
Rationale: Only unbound drug can readily distribute to receptors and undergo filtration. Reduced binding may
transiently increase active free concentrations, although distribution and clearance can subsequently change. Total
plasma concentration alone may be misleading for highly bound agents.
NR 565 | Original Practice Examination | 2026/2027 Page 2
, 3. An older adult begins a renally eliminated drug while estimated kidney function is substantially
reduced. What is the best prescribing response?
A) Use liver enzymes alone to select the dose
B) Adjust the regimen using renal function and drug guidance
C) Double the maintenance dose automatically
D) Assume age has no effect on exposure
Correct Answer: Adjust the regimen using renal function and drug guidance
Rationale: Reduced renal clearance can prolong exposure and raise toxicity risk. The dosing interval, amount, or both
may need adjustment according to validated guidance. Age alone is an imperfect proxy, so measured or estimated
kidney function and clinical response matter.
4. A drug's elimination half-life is 8 hours. Approximately how much remains 24 hours after a single dose,
assuming first-order elimination?
A) 25%
B) 12.5%
C) 50%
D) 33%
Correct Answer: 12.5%
Rationale: Twenty-four hours represents three half-lives. The amount remaining is one-half cubed, or one-eighth of the
initial amount. This approximation assumes first-order kinetics and does not account for additional doses or active
metabolites.
5. A patient has taken a fixed dose of a drug for one day and asks why concentrations have not
stabilized. What best explains steady state?
A) It usually takes roughly four to five elimination half-lives
B) It depends only on tablet color
C) It requires complete receptor saturation
D) It always occurs after exactly one dose
Correct Answer: It usually takes roughly four to five elimination half-lives
NR 565 | Original Practice Examination | 2026/2027 Page 3
, Rationale: With repeated dosing, drug input and elimination gradually approach balance. For many first-order drugs,
concentrations approach steady state after about four to five half-lives. Dose size changes the concentration reached,
not the approximate time required.
6. A medication has a narrow therapeutic index. Which management plan best reduces preventable
harm?
A) Use indicated serum monitoring and review interactions
B) Avoid documenting concurrent medications
C) Assume a normal pulse excludes toxicity
D) Increase doses until any adverse effect occurs
Correct Answer: Use indicated serum monitoring and review interactions
Rationale: The therapeutic and toxic concentrations are close for narrow-index drugs. When applicable, measured
concentrations, renal function, clinical effects, and interaction checks guide safe individualization. No single normal vital
sign reliably rules out medication toxicity.
7. A medication's potency increases while its maximal efficacy remains unchanged.
How would its dose-response curve usually change?
A) Show lower receptor affinity by definition
B) Become flat at all doses
C) Shift right with greater maximal response
D) Shift left without a higher maximal response
Correct Answer: Shift left without a higher maximal response
Rationale: A more potent drug produces a given response at a lower dose, often represented by a leftward shift.
Efficacy refers to the maximum attainable response. Potency does not by itself establish superior clinical outcomes or
safety.
8. Two agonists act at the same receptor; one produces a lower maximum response despite full receptor
occupancy. That drug is best described as what?
A) A partial agonist
B) A noncompetitive enzyme inhibitor
C) A full agonist with greater efficacy
D) An irreversible antagonist
NR 565 | Original Practice Examination | 2026/2027 Page 4
, NR 565 Midterm & Final Exams | Advanced Pharmacology | Chamberlain | 100 Q & A | 2026/2027
NR 565 MIDTERM EXAM
Advanced Pharmacology Fundamentals
Chamberlain University
100-Question Original Practice Examination
2026/2027 Edition
1. An oral medicine has extensive first-pass hepatic metabolism. Compared with an equal intravenous
dose, which result is most likely?
A) Elimination of hepatic exposure
B) An unchanged fraction reaching circulation
C) Higher absolute bioavailability
D) Lower systemic bioavailability
Correct Answer: Lower systemic bioavailability
Rationale: First-pass extraction removes some absorbed drug before it reaches systemic circulation. Intravenous
dosing bypasses intestinal absorption and the initial portal passage. Oral dose adjustments may therefore be
necessary, but the effect depends on the specific drug and liver function.
2. A medicine is 98% albumin-bound. Severe hypoalbuminemia is most likely to cause which immediate
change?
A) A complete loss of drug effect
B) A higher free fraction of drug
C) A fixed increase in renal clearance
D) A higher measured albumin concentration
Correct Answer: A higher free fraction of drug
Rationale: Only unbound drug can readily distribute to receptors and undergo filtration. Reduced binding may
transiently increase active free concentrations, although distribution and clearance can subsequently change. Total
plasma concentration alone may be misleading for highly bound agents.
NR 565 | Original Practice Examination | 2026/2027 Page 2
, 3. An older adult begins a renally eliminated drug while estimated kidney function is substantially
reduced. What is the best prescribing response?
A) Use liver enzymes alone to select the dose
B) Adjust the regimen using renal function and drug guidance
C) Double the maintenance dose automatically
D) Assume age has no effect on exposure
Correct Answer: Adjust the regimen using renal function and drug guidance
Rationale: Reduced renal clearance can prolong exposure and raise toxicity risk. The dosing interval, amount, or both
may need adjustment according to validated guidance. Age alone is an imperfect proxy, so measured or estimated
kidney function and clinical response matter.
4. A drug's elimination half-life is 8 hours. Approximately how much remains 24 hours after a single dose,
assuming first-order elimination?
A) 25%
B) 12.5%
C) 50%
D) 33%
Correct Answer: 12.5%
Rationale: Twenty-four hours represents three half-lives. The amount remaining is one-half cubed, or one-eighth of the
initial amount. This approximation assumes first-order kinetics and does not account for additional doses or active
metabolites.
5. A patient has taken a fixed dose of a drug for one day and asks why concentrations have not
stabilized. What best explains steady state?
A) It usually takes roughly four to five elimination half-lives
B) It depends only on tablet color
C) It requires complete receptor saturation
D) It always occurs after exactly one dose
Correct Answer: It usually takes roughly four to five elimination half-lives
NR 565 | Original Practice Examination | 2026/2027 Page 3
, Rationale: With repeated dosing, drug input and elimination gradually approach balance. For many first-order drugs,
concentrations approach steady state after about four to five half-lives. Dose size changes the concentration reached,
not the approximate time required.
6. A medication has a narrow therapeutic index. Which management plan best reduces preventable
harm?
A) Use indicated serum monitoring and review interactions
B) Avoid documenting concurrent medications
C) Assume a normal pulse excludes toxicity
D) Increase doses until any adverse effect occurs
Correct Answer: Use indicated serum monitoring and review interactions
Rationale: The therapeutic and toxic concentrations are close for narrow-index drugs. When applicable, measured
concentrations, renal function, clinical effects, and interaction checks guide safe individualization. No single normal vital
sign reliably rules out medication toxicity.
7. A medication's potency increases while its maximal efficacy remains unchanged.
How would its dose-response curve usually change?
A) Show lower receptor affinity by definition
B) Become flat at all doses
C) Shift right with greater maximal response
D) Shift left without a higher maximal response
Correct Answer: Shift left without a higher maximal response
Rationale: A more potent drug produces a given response at a lower dose, often represented by a leftward shift.
Efficacy refers to the maximum attainable response. Potency does not by itself establish superior clinical outcomes or
safety.
8. Two agonists act at the same receptor; one produces a lower maximum response despite full receptor
occupancy. That drug is best described as what?
A) A partial agonist
B) A noncompetitive enzyme inhibitor
C) A full agonist with greater efficacy
D) An irreversible antagonist
NR 565 | Original Practice Examination | 2026/2027 Page 4
